Fear, uncertainty, and doubt have become the norm in early 2025 with rising stock market volatility. David Jagielski (Eli ...
Circular Genomics, a biotechnology company, announced Monday that it had moved its headquarters from Albuquerque to San Diego, California. The company specializes in neurology and psychiatry research, ...
Citi reiterated a Buy rating and $1,190 price target on Eli Lilly (LLY), saying the firm expects a positive read-through to the shares on FDA’s ...
Several Protestant denominations are losing members, particularly the Episcopal, Presbyterian, Methodist and other historic ...
Dozens of foreign CEOs will visit Beijing this month for a flagship business conference and some will meet with President Xi ...
19h
Zacks Investment Research on MSNEli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should KnowEli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...
Twice-daily application of ruxolitinib cream demonstrated an ability to reduce itching and blistering in prurigo nodularis, a ...
AS the Formula 1 aces took to the grid this weekend, some fans were driven to distraction by the bevvy of beauties in the paddocks. The drivers’ glamorous wives and girlfriends  tried to keep ...
Proficio Capital Partners LLC increased its holdings in Eli Lilly by 30.2% during Q4, acquiring an additional 1,562 shares. Proficio now owns 6,739 shares of Eli Lilly, valued at $5.2 million. Several ...
Eli Lilly's stock is undervalued; defensive healthcare stocks shine amid uncertainty, and Eli Lilly drives growth. Click here ...
People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...
Senator Hickenlooper and Colorado Attorney General Phil Weiser joined a zoom call last week to discuss the legal ins and outs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results